Register for this scheme
The Government has committed up to £520m in capital grants for life sciences manufacturing, to help deliver on their mission to kickstart economic growth and build an NHS fit for the future.
The LSIMF will be UK and sector wide and will provide capital grants of between 10 and 20% of project costs for investments in the manufacture of:
- Human medicines (this includes both the manufacture of active pharmaceutical ingredients (API) / drug substance and finished product / drug product).
- Medical diagnostics – for both disease identification and monitoring.
- MedTech products – all types of medical devices related to human health.
Key scheme dates:
- Open now for EOIs
- April 2025: first grants awarded to successful projects
- Closing date: open until all funds allocated
To be eligible, your company must be a:
- UK registered company.
- Wholly private sector business.
- Product developer, contract development manufacturing organisation, or a generics manufacturer.
To be eligible, your project must:
- Have a total cost (capital and non-capital costs) of at least £8 million
- Be located in the UK
- Be primarily a capital investment
- Be a single company investment (as opposed to forming a partnership between companies or other types of organisations)
- Be a manufacturing project for the manufacture of: Human medicines, Medical diagnostics, MedTech products
- The fund is open to applications for both MHRA-licenced products and products in development where a MHRA licence is intended to be sought for commercial scale-up, for example a manufacturing project for clinical trials.